Skip to main content
. 2021 Sep 13;184(2):191–203. doi: 10.1093/toxsci/kfab112

Figure 4.

Figure 4.

Dolutegravir (DTG) alters gene expression levels in a dose-dependent manner. Quantitative reverse transcription-polymerase chain reaction analysis of day 2 aggregates. Graphs show averages of relative expression levels with error bars of SD. Open arrows indicate statistically significant differences (p < .02; 2-sample t test) compared with the corresponding control (0 μM).